Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
3(60.0%)
Phase 1
2(40.0%)
5Total
N/A(3)
Phase 1(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT06748963Not ApplicableRecruiting

Fasted Exercise Training in Type 1 Diabetes (FED-T1D)

Role: collaborator

NCT04116203Phase 1Completed

Dietary Fish Oil Intervention in Polycystic Ovary Syndrome (PCOS)

Role: collaborator

NCT03444064Phase 1Completed

PolyTreg Immunotherapy in Islet Transplantation

Role: collaborator

NCT02464514Not ApplicableCompleted

Macronutrient Regulation of Ghrelin and Peptide YY

Role: collaborator

NCT01144078Not ApplicableCompleted

Exercise Intensity, Glycemic Control and Abdominal Fat in People With Type 2 Diabetes: A Pilot Study

Role: collaborator

All 5 trials loaded